Genus plc Stock OTC Markets
Stocks
GENSY
US37253G1004
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
18:34:56 07/07/2026 +04
|
5-day change | 1st Jan Change | ||
| 28.38 USD | -9.18% |
|
-.--% | -24.90% |
| 09-10 | Europe mixed before ECB as US yields surge | AN |
| 09-10 | Genus lifts dividend, starts GBP60 million share buyback as profit up | AN |
| Market Cap | 1.43B 1.9B 1.68B 1.59B 2.7B 182B 2.74B 19B 7.31B 93.28B 7.15B 6.99B 299B | P/E 2026 |
5.05x | P/E 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.53B 2.03B 1.78B 1.69B 2.88B 194B 2.91B 20.23B 7.79B 99.34B 7.61B 7.44B 318B | EV / Sales 2026 |
2.29x | EV / Sales 2027 * | 2.29x |
| Free-Float |
99.24% | Yield 2026 |
1.64% | Yield 2027 * | 1.68% |
Last Transcript: Genus plc
| 1 day | -9.18% | ||
| 3 months | -9.18% | ||
| 6 months | -10.89% | ||
| Current year | -24.90% |
| Current year | 28.38 |  | 44.14 |
| 1 year | 28.38 | | 44.14 |
| 3 years | 21.71 | | 44.14 |
| 5 years | 21.71 | | 44.14 |
| 10 years | 21.71 | | 44.14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jorgen Kokke
CEO | Chief Executive Officer | 57 | 01/07/2023 |
Andy Russell
DFI | Director of Finance/CFO | - | 01/08/2025 |
Matt Culbertson
COO | Chief Operating Officer | - | 01/01/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Lysanne Gray
BRD | Director/Board Member | 62 | 01/04/2016 |
Lesley Knox
BRD | Director/Board Member | 73 | 01/06/2018 |
Iain Ferguson
CHM | Chairman | 71 | 25/11/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.18% | -.--% | - | - | 1.9B | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.47% | +0.96% | +27.43% | +80.47% | 60.14B | |
| -1.32% | -0.35% | +6.25% | +35.08% | 48.15B | |
| -0.05% | +0.37% | +41.54% | +36.65% | 44.25B | |
| +0.38% | +7.61% | +339.53% | +641.55% | 43.99B | |
| +0.18% | +0.26% | +7.41% | +103.45% | 41.61B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -1.29% | -3.55% | -20.74% | +352.04% | 24.93B | |
| Average | -0.35% | +1.53% | +55.02% | +156.95% | 44.09B | |
| Weighted average by Cap. | +0.78% | +1.53% | +59.22% | +147.49% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 666M 884M 778M 737M 1.25B 84.75B 1.27B 8.82B 3.4B 43.32B 3.32B 3.25B 139B | 659M 874M 770M 730M 1.24B 83.84B 1.26B 8.73B 3.36B 42.86B 3.28B 3.21B 137B |
| Net income | 169M 224M 197M 187M 318M 21.5B 322M 2.24B 861M 10.99B 842M 824M 35.24B | 48.33M 64.17M 56.51M 53.54M 91.1M 6.15B 92.27M 641M 247M 3.15B 241M 236M 10.08B |
| Net Debt | 93.22M 124M 109M 103M 176M 11.87B 178M 1.24B 475M 6.07B 465M 455M 19.45B | 75.91M 101M 88.74M 84.08M 143M 9.66B 145M 1.01B 387M 4.94B 378M 370M 15.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | $0.000000 | - | 1 |
| 29/09/26 | $0.000000 | - | 6 |
| 25/09/26 | $0.000000 | - | 2 |
| 24/09/26 | $0.000000 | - | 7 |
| 22/09/26 | $0.000000 | - | 9 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GNS Stock
- GENSY Stock
Select your edition
All financial news and data tailored to specific country editions
